Epigenetic repurposing of carbohydrate metabolic inhibitors for insulin resistance: targeting DNMT1 and HDAC3 for β-cell restoration

Muhammad Javid Iqbal, Luis A. Salazar

Open source

DOI
10.3389/freae.2025.1691949
Published
2025-10-30
Container
Frontiers in Epigenetics and Epigenomics
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/freae.2025.1691949,
  title = {Epigenetic repurposing of carbohydrate metabolic inhibitors for insulin resistance: targeting DNMT1 and HDAC3 for β-cell restoration},
  author = {Muhammad Javid Iqbal and Luis A. Salazar},
  year = {2025},
  journal = {Frontiers in Epigenetics and Epigenomics},
  doi = {10.3389/freae.2025.1691949},
  url = {https://doi.org/10.3389/freae.2025.1691949}
}

RIS

TY  - JOUR
TI  - Epigenetic repurposing of carbohydrate metabolic inhibitors for insulin resistance: targeting DNMT1 and HDAC3 for β-cell restoration
AU  - Muhammad Javid Iqbal
AU  - Luis A. Salazar
PY  - 2025
JO  - Frontiers in Epigenetics and Epigenomics
DO  - 10.3389/freae.2025.1691949
UR  - https://doi.org/10.3389/freae.2025.1691949
ER  - 

APA

Iqbal, M. J., & Salazar, L. A. (2025). Epigenetic repurposing of carbohydrate metabolic inhibitors for insulin resistance: targeting DNMT1 and HDAC3 for β-cell restoration. Frontiers in Epigenetics and Epigenomics. https://doi.org/10.3389/freae.2025.1691949

Source records